Increase in urolithiasis prevalence due to vitamins C and D supplementation during the COVID-19 pandemic

J Public Health (Oxf). 2022 Dec 1;44(4):e625-e626. doi: 10.1093/pubmed/fdab328.
No abstract available

Keywords: COVID-19; kidney stone; urolithiasis; vitamin C; vitamin D.

Publication types

  • Letter

MeSH terms

  • Ascorbic Acid / therapeutic use
  • COVID-19*
  • Dietary Supplements
  • Humans
  • Pandemics
  • Prevalence
  • Urolithiasis*
  • Vitamin D / therapeutic use
  • Vitamins / therapeutic use

Substances

  • Ascorbic Acid
  • Vitamins
  • Vitamin D